Revision of road traffic law in Japan and mental health stigma

Nakagami, Yukako; Sugihara, Genichi; Kuga, Hironori; Takahashi, Hidehiko; Murai, Toshiya

doi:10.1111/pcn.12831

Cited by 2 publications

(2 citation statements)

References 2 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…The results of the multiple regression analyses performed to predict the PAP scores are presented in Table 5. A significant association was found (F [10,277]=8.88, p<0.001), with an R 2 of 0.243. The policy factor was significantly negatively predicted by the PAP scores (β=-0.20, p=0.004).…”

Section: Results Of Multiple Linear Regression Analyses On Predicting the Psychiatrists' Attitudes Toward Polypharmacy Scoresmentioning

confidence: 94%

“…This association between the limitation on the use of psychotropic drugs and lower PAP scores is compatible with the hypothesis that the Japanese polypharmacy reduction policy has influenced psychiatrists’ attitudes and reduced the prevalence of polypharmacy. To the best of our knowledge, this is the first report indicating the effect of policy on PAP, although the effects of policy on attitudes toward mental disorders [ 10 ] and smoking behavior [ 11 ] have been reported previously.…”

Section: Discussionmentioning

confidence: 99%

See 1 more Smart Citation

A Call for a Rational Polypharmacy Policy: International Insights From Psychiatrists

Nakagami

Hayakawa

Horinouchi

et al. 2021

Psychiatry Investig

Self Cite

View full text Add to dashboard Cite

Objective Recently, rational polypharmacy approaches have been proposed, regardless of the lower risk and cost of monotherapy. Considering monotherapy as first-line treatment and polypharmacy as rational treatment, a balanced attitude toward polypharmacy is recommended. However, the high prevalence of polypharmacy led the Japanese government to establish a polypharmacy reduction policy. Based on this, the association between the policy and psychiatrists’ attitude toward polypharmacy has been under debate.Methods We developed an original questionnaire about Psychiatrists’ attitudes toward polypharmacy (PAP). We compared the PAP scores with the treatment decision-making in clinical case vignettes. Multiple regression analyses were performed to quantify associations of explanatory variables including policy factors and PAP scores. The anonymous questionnaires were administered to psychiatrists worldwide.Results The study included 347 psychiatrists from 34 countries. Decision-making toward polypharmacy was associated with high PAP scores. Multiple regression analysis revealed that low PAP scores were associated with the policy factor (β=-0.20, p=0.004). The culture in Korea was associated with high PAP scores (β=0.34, p<0.001), whereas the culture in India and Nepal were associated with low scores (β=-0.15, p=0.01, and β=-0.17, p=0.006, respectively).Conclusion Policy on polypharmacy may influence psychiatrists’ decision-making. Thus, policies considering rational polypharmacy should be established.

show abstract

Section: Results Of Multiple Linear Regression Analyses On Predicting the Psychiatrists' Attitudes Toward Polypharmacy Scoresmentioning

confidence: 94%

Section: Discussionmentioning

confidence: 99%